morbid
mortal
loss
product
enter
diseas
neonat
piglet
cost
swine
produc
million
dollar
annual
porcin
epidem
diarrhea
viru
pedv
outbreak
led
million
billion
annual
loss
us
swine
produc
passiv
lactogen
immun
remain
promis
effect
way
protect
neonat
suckl
piglet
enter
diseas
like
pedv
protect
suckl
piglet
lactogen
immun
depend
traffick
pathogenspecif
iga
plasmablast
mammari
gland
accumul
secretori
iga
siga
antibodi
milk
defin
gutmammarysiga
axi
due
imperm
placenta
piglet
born
agammaglobulin
highli
suscept
plethora
infecti
agent
reli
sole
colostrum
milk
antibodi
matern
lactogen
immun
previou
advanc
develop
live
attenu
vaccin
anoth
devast
diarrheal
viru
pig
transmiss
gastroenter
viru
tgev
provid
insight
mechan
matern
immun
piglet
protect
chapter
review
previou
research
tgevinduc
lactogen
immun
provid
histor
perspect
current
effort
pedv
control
vaccin
swine
industri
identifi
factor
influenc
lactogen
immun
gutmammarysiga
axi
may
lead
improv
vaccin
regimen
pedv
enter
pathogen
gestat
swine
improv
overal
herd
immun
swine
health
industri
product
neutral
antibodi
pedv
vaccin
passiv
protect
piglet
primeboost
matern
vaccin
strategi
enhanc
piglet
protect
seroposit
herd
new
alphacoronaviru
pedv
first
emerg
fatten
pig
european
swine
herd
becam
widespread
sever
nurs
piglet
vaccin
use
pedv
case
becam
rare
europ
sporad
outbreak
howev
reemerg
pedv
outbreak
multipl
countri
europ
sinc
report
recent
boniotti
et
al
dastjerdi
et
al
denni
et
al
grasland
et
al
martelli
et
al
stadler
et
al
theun
et
al
due
pedv
outbreak
occur
asian
swine
herd
diseas
becam
widespread
ultim
endem
song
park
subsequ
attenu
inactiv
pedv
vaccin
develop
use
wide
asia
nevertheless
sinc
sever
pedv
outbreak
highli
virul
pedv
strain
report
throughout
contin
unexplain
reason
vaccin
base
european
classic
pedv
strain
fail
control
recent
virul
pedv
strain
asia
song
park
pedv
emerg
us
new
devast
diarrheal
diseas
swine
pedv
spread
rapidli
throughout
us
infect
swine
age
caus
major
econom
loss
swine
industri
stevenson
et
al
also
spread
canada
mexico
ojkic
et
al
genet
us
pedv
strain
resembl
recent
highli
virul
strain
china
china
origin
pedv
us
remain
unknown
huang
et
al
marthal
et
al
vlasova
et
al
emerg
diseas
cours
pedv
resembl
anoth
alphacoronaviru
tgev
caus
epizoot
diarrhea
outbreak
sever
loss
nurs
pig
us
saif
et
al
although
attenu
tgev
vaccin
develop
protect
effect
greatest
impact
epidemiolog
sever
tgev
emerg
respiratori
variant
tgev
porcin
respiratori
coronaviru
prcv
emerg
winter
pensaert
et
al
saif
et
al
prcv
spread
wide
swine
europ
asia
us
gener
moder
sever
tgev
dramat
reduc
potenti
elimin
incid
tgev
certain
region
ie
western
europ
due
high
virul
pedv
immatur
immun
system
neonat
suckl
piglet
passiv
lactogen
immun
pedv
critic
suckl
piglet
protect
appear
like
tgev
lactogen
immun
gutmammari
glandsiga
axi
may
also
play
key
role
lactogen
immun
pedv
understand
gutmammarysiga
link
critic
ensur
herd
health
recoveri
pedv
outbreak
vaccin
design
prevent
futur
pedv
outbreak
review
focu
lactogen
immun
design
matern
vaccin
pedv
like
epizoot
tgev
pedv
fatal
nurs
piglet
induct
lactogen
immun
tgev
review
provid
histor
perspect
pedv
vaccin
pedv
tgev
mainli
local
intestin
infect
transient
viremia
base
viral
rna
detect
serum
young
piglet
sever
infect
greatest
newborn
piglet
thu
vaccin
strategi
diseas
must
focu
induct
mucos
immun
protect
target
intestin
enterocyt
necessit
protect
level
mucos
immun
neonat
birth
throughout
nurs
period
two
major
issu
direct
vaccin
pedv
neonat
piglet
seroposit
sow
matern
antibodi
may
interfer
live
oral
vaccineinduc
protect
piglet
three
week
need
actual
antibodi
product
piglet
consequ
immun
induc
mucos
site
pregnant
sow
passiv
transfer
suckl
piglet
via
colostrum
milk
lactogen
immun
crucial
immedi
protect
neonat
enter
infect
recogn
prior
studi
passiv
immun
tgev
sow
recov
tgev
infect
protect
expos
litter
tgev
protect
associ
high
level
antibodi
milk
lactogen
immun
serum
sow
bohl
saif
saif
et
al
howev
mechan
induc
protect
level
milk
antibodi
lactogen
immun
unknown
hinder
develop
effect
tgev
matern
vaccin
likewis
addit
unansw
question
relat
induct
lactogen
immun
enter
pathogen
may
also
impact
efficaci
pedv
vaccin
sever
key
immunolog
find
emerg
earli
work
tgev
vaccin
saif
saif
et
al
due
imperm
placenta
sow
piglet
born
agammaglobulin
reli
sole
colostrum
milk
antibodi
passiv
immun
saif
jackwood
leav
newborn
piglet
highli
suscept
plethora
infecti
agent
sow
igg
domin
colostrum
transud
sow
serum
klobasa
et
al
newborn
piglet
acquir
colostr
antibodi
mainli
igg
via
nurs
immunoglobulin
transport
across
piglet
intestin
epithelium
within
first
h
birth
next
day
transit
milk
siga
becom
domin
persist
milk
throughout
lactat
thu
igg
antibodi
absorb
sow
colostrum
provid
piglet
serum
antibodi
reflect
specif
sow
serum
prevent
system
infect
contrast
iga
antibodi
domin
milk
function
provid
local
passiv
protect
piglet
intestin
tract
enigma
delin
origin
iga
immunocyt
mammari
gland
secret
siga
antibodi
milk
knowledg
critic
aid
design
enter
vaccin
induc
passiv
milk
siga
antibodi
besid
milk
siga
domin
ig
mucos
surfac
mucos
secret
macpherson
et
al
manti
et
al
resist
proteolyt
enzym
afford
siga
high
level
stabil
gastrointestin
tract
tgev
research
provid
basic
understand
concept
lactogen
immun
well
vaccin
strategi
induct
seroneg
pregnant
swine
discoveri
bohl
saif
gutmammarysiga
axi
traffick
iga
immunocyt
gut
mammari
gland
swine
forerunn
concept
common
mucos
immun
system
saif
saif
bohl
saif
et
al
weiszcarrington
et
al
provid
explan
sow
natur
infect
oral
inocul
live
tgev
recov
infect
high
persist
level
siga
antibodi
milk
protect
piglet
tge
howev
sow
system
immun
inactiv
tgev
vaccin
mainli
igg
antibodi
serum
colostrum
declin
rapidli
milk
provid
littl
lactogen
immun
piglet
discoveri
led
matern
vaccin
strategi
induc
mucos
passiv
immun
applic
multipl
speci
multipl
enter
pathogen
includ
pedv
lymphocyt
continu
circul
throughout
bodi
blood
lymphoid
tissu
provid
immun
surveil
invad
pathogen
maintain
homeostasi
butcher
picker
gowan
cell
migrat
home
secondari
lymphoid
organ
cross
special
blood
vessel
known
high
endotheli
venul
b
lymphocyt
extravas
high
endotheli
venul
multistep
process
involv
roll
adhes
transmigr
local
within
respect
lymph
node
springer
differenti
express
surfac
ligand
receptor
lymphocyt
endotheli
cell
well
express
chemotact
factor
chemokin
distinguish
peripher
mucos
home
site
distinct
system
mucos
lymphocyt
home
import
understand
mucos
immun
respons
vaccin
design
system
vs
mucos
pathogen
instanc
control
peripher
migrat
regul
lymphocyt
cellular
ligand
lselectin
chemokin
receptor
ccr
interact
vascular
cellular
adhes
molecul
peripher
node
addressin
pnad
chemokin
ligand
ccl
respect
miyasaka
tanaka
howev
traffick
mucos
tissu
specif
intestin
larg
regul
interact
mucos
addressin
cellular
adhes
molecul
briskin
et
al
marui
et
al
chemokin
secret
high
endotheli
venul
tissu
play
signific
role
mucos
lymphocyt
migrat
defin
home
local
ie
tissu
specif
lymphocyt
traffick
miyasaka
tanaka
mediat
direct
migrat
lymphocyt
chemokin
bind
g
proteincoupl
receptor
cellular
surfac
inhibit
adenylyl
cyclas
mobil
intracellular
ca
dixit
simon
receptor
activ
chemokin
bind
membraneteth
extracellular
matrixassoci
glycosaminoglycan
lymphoid
organ
tissu
creat
chemokin
gradient
proudfoot
et
al
intestin
secret
endotheli
cell
bind
lymphocyt
respect
stenstad
et
al
wang
et
al
wurbel
et
al
estim
iga
antibodysecret
cell
asc
locat
gut
associ
lymphoid
tissu
suzuki
et
al
macpherson
slack
therefor
initi
specif
traffick
signal
need
effici
migrat
mucos
b
cell
swine
imper
enter
diseas
prevent
clearanc
instanc
studi
intestin
infect
enteropathogen
rotaviru
short
window
time
exist
day
primari
challeng
day
secondari
challeng
traffick
gutderiv
lymphocyt
iga
asc
detect
blood
transient
traffick
cell
blood
mirror
stimul
gut
home
back
intestin
mucos
site
brown
et
al
ward
et
al
yuan
et
al
studi
highlight
import
identifi
window
time
swine
traffick
signal
initi
lymphocyt
migrat
stimul
gut
circul
traffic
mucos
site
like
mammari
gland
addit
home
marker
like
may
use
correl
pedv
viral
clearanc
appear
memori
b
cell
correl
rotaviru
clearanc
gut
mice
william
et
al
bourg
colleagu
profil
differenti
express
adhes
molecul
chemokin
differ
mucos
site
swine
bourg
et
al
express
measur
mean
fluoresc
intens
lamina
propria
intraepitheli
iga
b
lymphocyt
higher
nasal
mucosa
peripher
blood
lymphocyt
compar
howev
opposit
true
intraepithelium
intestin
express
iga
b
lymphocyt
higher
express
differenti
express
nasal
small
intestin
mucosa
also
demonstr
vascular
addressin
measur
pnad
express
blood
vessel
nasal
lamina
propria
detect
intestin
blood
vessel
opposit
true
express
detect
small
intestin
nasal
lamina
propria
suggest
mucos
home
characterist
pig
tissu
specif
compar
seen
human
mice
butcher
picker
addit
mucos
chemokin
express
associ
receptor
exhibit
tissu
specif
swine
well
exhibit
low
mrna
express
respiratori
tissu
higher
express
intestin
particularli
small
intestin
high
level
express
small
larg
intestin
well
trachea
express
ubiquit
intestin
respiratori
tissu
swine
high
express
local
small
larg
intestin
mesenter
lymph
node
mammari
gland
evalu
role
adhes
molecul
chemokin
healthi
infect
swine
integr
understand
diseas
pathogenesi
host
immun
respons
develop
effect
vaccin
understand
lymphocyt
traffick
signal
involv
swine
integr
further
understand
immun
respons
enter
pathogen
like
pedv
optim
vaccin
efficaci
target
time
intestin
lymphocyt
respons
mucos
traffick
swine
lead
enhanc
lactogen
immun
decreas
morbid
mortal
neonat
suckl
piglet
well
document
immun
pregnant
anim
provid
passiv
protect
suckl
neonat
bacteri
viral
infect
bohl
saif
bohl
et
al
kortbeekjacob
et
al
lanza
et
al
moon
bunn
saif
et
al
saif
fernandez
saif
et
al
wilson
et
al
lactogen
immun
describ
continu
suppli
passiv
acquir
immunoglobulin
igg
igm
siga
ingest
colostrum
milk
igg
domin
isotyp
colostrum
siga
milk
klobasa
et
al
abund
antibodi
gut
secret
siga
gener
transloc
intestin
plasma
fig
schemat
depict
gutmammarysiga
axi
traffick
molecul
provid
suffici
pedvspecif
immun
colostrummilk
depend
traffick
iga
plasmablast
immatur
plasma
cell
intestin
mammari
gland
accumul
siga
antibodi
milk
traffick
lymphocyt
mucos
tissu
larg
regul
interact
interact
traffick
system
site
regul
lselect
interact
pnad
respect
adapt
chattha
et
al
cellproduc
dimer
iga
gut
lumen
via
polymer
immunoglobulin
receptor
basolater
surfac
epitheli
cell
fig
lumen
siga
provid
immun
protect
contribut
intestin
homeostasi
macpherson
et
al
manti
et
al
gutmammarysiga
axi
initi
intestin
mean
natur
infect
oral
vaccin
plasmablast
must
traffic
mammari
gland
suppli
specif
immun
via
mammari
secret
describ
earlier
migrat
iga
plasmablast
cell
intestin
mediat
mostli
surfac
integrin
interact
interact
respect
howev
home
marker
consist
shown
regul
migrat
iga
plasmablast
mammari
gland
mice
interact
block
mice
level
iga
antibodi
milk
reduc
result
lack
ingest
iga
nurs
mous
wilson
butcher
addit
mous
model
iga
asc
accumul
mammari
gland
abolish
morteau
et
al
studi
replic
swine
associ
evid
exist
mice
swine
highli
express
mammari
gland
lactat
lazaru
et
al
increas
mammari
gland
swine
coincid
number
accumul
iga
b
cell
cours
gestat
bourg
et
al
meuren
et
al
addit
protein
detect
sow
milk
provid
evid
suggest
role
chemokin
lactogen
immun
sow
sow
express
blood
vessel
endotheli
cell
mammari
gland
increas
end
gestat
earli
lactat
bourg
et
al
bind
implic
recruit
iga
plasmablast
mammari
gland
swine
mice
contrari
evid
exist
speci
postigo
et
al
tanneau
et
al
mice
function
blockad
diminish
accumul
iga
milk
low
et
al
furthermor
swine
small
fraction
total
iga
b
cell
mammari
gland
express
migrat
mammari
gland
bourg
et
al
result
suggest
interact
may
import
gutmammarysiga
axi
mechan
action
may
exist
integrin
respect
addressin
howev
associ
migrat
lymphocyt
mammari
gland
mice
swine
express
iga
b
cell
detect
mammari
gland
lactat
higher
number
express
iga
b
cell
addit
express
mammari
gland
prior
farrow
lactat
bourg
et
al
mice
treat
serum
iga
asc
accumul
lactat
mammari
gland
inhibit
low
et
al
data
suggest
cell
traffick
mice
may
also
depend
interact
also
import
consid
possibl
speci
differ
lymphoid
structur
mice
swine
may
contribut
dissimilar
report
literatur
rothkott
lack
research
swine
necess
investig
corrobor
result
obtain
mous
studi
traffick
immunocyt
mammari
gland
monitor
analyz
b
cell
chemotact
factor
mammari
gland
tissu
secret
cours
gestat
dynam
chang
bt
immunocyt
composit
accumul
mammari
gland
parallel
chang
mrna
express
well
instanc
first
trimest
iga
b
cell
cell
number
low
littl
express
mammari
gland
second
trimest
cell
increas
mammari
gland
iga
b
cell
number
remain
similar
seen
first
trimest
third
trimest
cell
accumul
mammari
gland
peak
moder
increas
seen
iga
b
cell
number
express
time
anim
farrow
iga
b
cell
number
reach
peak
express
continu
increas
lactat
bourg
et
al
chabaudi
et
al
meuren
et
al
exemplifi
import
traffick
b
cell
immunolog
mammari
gland
subsequ
antibodi
secret
colostrum
milk
understand
kinet
immunocyt
migrat
mammari
gland
late
gestat
imper
regul
lactogen
immun
like
initi
gutmammarysiga
axi
mean
natur
infect
oral
vaccin
giltssow
requir
optim
traffick
pathogenspecif
b
cell
variabl
includ
pariti
gestat
stage
dose
requir
initi
remain
unknown
discuss
sever
variabl
follow
section
recent
case
studi
sow
farm
us
becam
posit
pedv
farm
given
feedback
exposur
oral
live
viru
exposur
olv
purpos
induc
lactogen
immun
sow
howev
nearli
one
year
olv
initi
pedv
detect
facil
diagnos
strain
breakout
time
entir
farm
given
second
round
olv
nine
week
second
olv
first
pariti
gilt
higher
mortal
piglet
compar
second
third
fourth
fifth
sixth
seventh
eighth
ninth
pariti
gilt
ackerman
decreas
piglet
mortal
higher
pariti
sow
could
attribut
higher
level
immun
factor
serum
lactogen
secret
instanc
sow
igg
iga
immunoglobulin
level
serum
colostrum
milk
piglet
iga
immunoglobulin
level
serum
higher
multipar
compar
first
pariti
sow
piglet
respect
cabrera
et
al
klobasa
et
al
van
de
ligt
et
al
addit
pariti
impact
rotaviru
vaccin
efficaci
rumin
multipar
cow
higher
antibodi
titer
lactogen
secret
requir
fewer
dose
vaccin
compar
primipar
cow
saif
fernandez
howev
explan
may
exist
pedv
result
includ
age
first
pedv
exposur
instanc
gilt
farrow
would
first
expos
pedv
neonat
piglet
sow
farrow
would
first
expos
pedv
older
anim
possibl
older
anim
abl
gener
larger
pool
pedvspecif
memori
b
cell
result
greater
anamnest
respons
second
olv
exposur
addit
increas
amount
mammari
tissu
multipar
sow
may
coincid
increas
number
resid
memori
b
cell
gland
research
need
determin
pariti
age
pedv
exposur
combin
two
impact
lactogen
immun
subsequ
neonat
protect
mention
earlier
gestat
stage
anim
influenc
kinet
lymphocyt
lymphoblast
accumul
mammari
gland
instanc
day
gestat
sow
cell
number
peak
mammari
gland
cell
per
unit
mm
microscop
field
decreas
cell
unit
mm
microscop
field
lactat
howev
iga
b
cell
number
peak
day
postpartum
approxim
cell
per
unit
mm
microscop
field
remain
approxim
cell
per
unit
mm
microscop
field
lactat
bourg
et
al
chabaudi
et
al
addit
increas
mammari
gland
express
end
gestat
lactat
coincid
increas
b
cell
sow
bourg
et
al
mice
siga
lymphoblast
preferenti
migrat
mammari
gland
mesenter
lymph
node
rather
peripher
lymph
node
toward
end
gestat
lactat
roux
et
al
result
suggest
gestat
stage
influenc
lymphocyt
traffick
mammari
gland
dearth
inform
impact
gestat
stage
immun
enter
virus
like
pedv
tgev
howev
draw
comparison
research
done
alter
state
immun
respons
pregnant
women
instanc
decreas
ratio
type
helper
cell
pregnanc
progress
women
yamaguchi
et
al
chang
cytokin
profil
also
correspond
chang
immun
respons
like
lymphocyt
traffick
even
convinc
chang
immunolog
state
pregnanc
pregnant
women
second
trimest
higher
natur
killer
cell
respons
vaccin
compar
women
third
trimest
kay
et
al
conceiv
differ
gestat
stage
immun
respons
relat
drastic
chang
hormon
concentr
pregnant
women
anim
experi
earli
report
administr
estrogen
progesteron
prolactin
ovariectom
mice
enhanc
mesenter
lymph
nodederiv
iga
plasmablast
recruit
mammari
gland
first
evid
show
pregnancyassociatedmammogen
hormon
influenc
lymphocyt
traffick
intestin
mammari
gland
weiszcarrington
et
al
studi
replic
swine
speci
associ
evid
exist
hormon
level
lymphocyt
recruit
mammari
gland
instanc
express
predominantli
end
gestat
lactat
increas
integrin
express
lactat
bourg
et
al
addit
swine
correl
increas
densiti
prolactin
receptor
mammari
epitheli
cell
rate
lymphocyt
accumul
mammari
gland
salmon
prolactin
also
report
upregul
polymer
immunoglobulin
receptor
pigr
mammari
gland
rabbit
sheep
known
pigr
facilit
select
migrat
siga
across
mucos
epithelium
kaetzel
swine
pigr
mediat
secret
iga
igm
lactogen
secret
free
secretori
compon
detect
colostrum
milk
kumura
et
al
le
jan
littl
research
done
area
hormonecontrol
lymphocyt
traffick
sinc
mani
unansw
question
pregnant
giltsow
experi
dynam
chang
circul
plasma
hormon
level
unlik
human
whose
estrogen
progesteron
level
consist
increas
throughout
pregnanc
plummet
parturit
swine
progesteron
domin
first
trimest
estrogen
prolactin
domin
third
trimest
lactat
respect
foisnet
et
al
krael
et
al
robertson
king
dramat
increas
estrogen
prolactin
concentr
third
trimest
follow
subsequ
pedv
rna
fecal
titer
highest
postinocul
highdos
pedvinocul
gilt
pedv
rna
fecal
titer
increas
contact
expos
gilt
piglet
pedv
challeng
lowdos
pedv
mockinocul
gilt
highest
viral
titer
suggest
immun
protect
previous
highdos
pedvinocul
gilt
b
pedv
rna
fecal
titer
increas
piglet
pedv
challeng
piglet
born
lowdos
pedv
mockinocul
gilt
higher
viral
titer
suggest
lower
immun
protect
increas
express
number
iga
cell
mammari
gland
bourg
et
al
meuren
et
al
evid
estrogen
prolactin
impact
iga
plasmablast
home
exist
mice
research
demonstr
directli
swine
also
unclear
hormon
affect
gutmammarysiga
axi
swine
infect
deduc
mechan
hormon
influenc
home
ligand
receptor
express
gutmammarysiga
axi
target
anim
immunolog
respons
enter
infect
vaccin
pregnanc
current
studi
lab
demonstr
exposur
dose
pedv
gestat
may
influenc
lactogen
immun
protect
pedvchalleng
neonat
piglet
six
gilt
day
gestat
third
trimest
oral
inocul
origin
highli
virul
us
pedv
strain
either
log
ge
genom
equival
log
plaqu
form
unit
pfu
n
high
dose
log
ge
log
pfu
n
low
dose
gnotobiot
pigpassag
virul
strain
pedv
mock
inocul
n
neg
control
day
age
piglet
oral
challeng
log
ge
log
pfu
pedv
homolog
strain
viru
shed
rectal
swab
quantifi
realtim
quantit
reversetranscript
polymeras
chain
reaction
rtqpcr
diarrhea
score
record
daili
describ
previous
oka
et
al
viru
neutral
antibodi
detect
serum
whey
use
plaqu
reduct
assay
modifi
previous
publish
protocol
tgev
lanza
et
al
pedv
lin
et
al
vero
cell
cultur
adapt
origin
virul
pedv
strain
use
oka
et
al
plaqu
count
viru
neutral
titer
express
reciproc
highest
dilut
serum
whey
show
reduct
number
plaqu
high
dose
pedvinocul
gilt
shed
higher
viral
rna
titer
log
geml
fecal
sampl
detect
one
day
earlier
persist
longer
postgilt
inocul
low
dose
pedvinocul
gilt
fig
addit
high
low
dose
pedvinocul
gilt
lower
delay
peak
fecal
viral
rna
titer
postpiglet
challeng
compar
mockinocul
gilt
contact
expos
pedvinocul
piglet
fig
litter
born
high
dose
pedvinocul
gilt
delay
lower
pedv
rna
fecal
titer
throughout
postpiglet
challeng
day
pcd
mean
diarrhea
score
defin
wateri
diarrhea
throughout
compar
low
dose
pedv
mockinocul
litter
fig
c
demonstr
greater
passiv
protect
diseas
infect
low
dose
mock
gilt
litter
shed
higher
pedv
rna
level
fece
earlier
prolong
period
mainli
mock
litter
interestingli
pedv
high
dose
inocul
pregnant
gilt
lactat
mockinocul
gilt
expos
pedv
challeng
piglet
higher
peak
pedv
rna
titer
fece
log
geml
mean
log
geml
respect
mean
peak
pedv
rna
titer
log
geml
challeng
piglet
mockinocul
gilt
data
suggest
pedvchalleng
seroneg
piglet
mock
gilt
litter
like
shed
high
fecal
rna
level
also
pedv
seroneg
pregnant
lactat
gilt
may
shed
high
titer
pedv
rna
fece
contribut
viral
contamin
transmiss
farm
high
dose
pedvinocul
gilt
provid
greater
protect
mortal
pedvchalleng
piglet
compar
low
dose
mortal
mockinocul
mortal
gilt
correspond
increas
mean
pedv
neutral
antibodi
titer
serum
gilt
mean
post
inocul
day
pid
colostrum
milk
gilt
mean
postpartum
day
ppd
high
dose
gilt
fig
b
instanc
high
dose
pedvinocul
gilt
pedv
neutral
antibodi
titer
serum
detect
gilt
pid
pcd
howev
pedv
neutral
antibodi
titer
delay
serum
low
dose
pedvinocul
gilt
detect
gilt
pid
pcd
milk
high
dose
pedvinocul
gilt
higher
pedv
neutral
antibodi
titer
colostrum
milk
throughout
lactat
low
dose
mockinocul
gilt
except
gilt
pid
pcd
similarli
expect
primari
immun
respons
pedv
delay
respons
mean
pedv
neutral
antibodi
titer
serum
gilt
pid
pcd
earlier
respons
milk
mockinocul
gilt
gilt
pid
pcd
milk
pedv
neutral
antibodi
titer
low
dose
pedvinocul
gilt
remain
lower
throughout
lactat
high
dose
pedvinocul
gilt
reach
approxim
higher
titer
gilt
pid
pcd
result
suggest
increas
viral
replic
higher
viral
rna
shed
fece
high
dose
pedvinocul
gilt
result
earlier
increas
viru
neutral
antibodi
titer
serum
milk
greater
piglet
protect
studi
repeat
addit
gilt
sow
confirm
preliminari
find
well
complet
addit
immunolog
assay
hypothes
increas
pedv
replic
gut
reflect
viral
rna
shed
fece
lead
increas
iga
plasmablast
memori
b
cell
gener
gut
iga
immunocyt
traffic
mammari
gland
provid
passiv
lactogen
immun
neonat
suckl
piglet
identifi
correl
immun
infect
vaccin
pertin
assess
suscept
individu
anim
herd
understand
relationship
infectionvaccin
host
immun
respons
clinic
sign
subsequ
protect
regard
lactogen
immun
role
antibodi
play
host
defens
best
exemplifi
protect
provid
neonat
matern
antibodi
saif
zinkernagel
well
document
swine
give
birth
agammaglobulin
offspr
due
imperm
placenta
kim
et
al
matern
antibodi
provid
necessari
lactogen
immun
need
neonat
piglet
immun
defens
endogen
antibodi
produc
suffici
amount
correl
immun
previous
identifi
enter
virus
like
tgev
rotaviru
mention
earlier
increas
rate
protect
tgev
neonat
piglet
associ
high
titer
siga
antibodi
colostrum
milk
bohl
saif
saif
et
al
addit
lab
first
identifi
iga
asc
traffick
blood
intestin
immunolog
marker
protect
activ
gut
immun
anim
model
humanrotavirusinduc
diseas
studi
rotavirusspecif
iga
asc
igg
asc
blood
correl
iga
asc
intestin
subsequ
c
litter
born
highdos
pedv
inocul
gilt
delay
lower
pedv
rna
fecal
titer
throughout
postpiglet
challeng
day
pcd
mean
diarrhea
score
defin
wateri
diarrhea
throughout
compar
lowdos
pedv
mock
inocul
litter
pedv
inocul
piglet
monitor
clinic
sign
time
daili
necropsi
diarrhea
assess
score
fecal
consist
follow
solid
pasti
semiliquid
liquid
score
consid
diarrheic
ab
pedv
rna
titer
fecal
sampl
determin
qrtpcr
detect
limit
qrtpcr
geml
ac
bar
repres
mean
sem
abbrevi
postinocul
day
pid
piglet
challeng
day
pcd
serum
pedv
neutral
antibodi
titer
first
detect
high
dose
pedvinocul
gilt
mean
gilt
postinocul
day
pid
mean
piglet
challeng
day
pcd
low
dose
pedvinocul
gilt
neutral
antibodi
titer
delay
detect
gilt
mean
pid
piglet
pcd
pedv
neutral
antibodi
titer
detect
mockinocul
gilt
gilt
mean
pid
piglet
pcd
b
milk
pedv
neutral
antibodi
titer
highest
colostrum
milk
high
dose
pedvinocul
gilt
serum
milk
pedv
neutral
antibodi
titer
delay
mockinocul
gilt
mean
pid
piglet
pcd
mean
pid
piglet
pcd
respect
mean
gilt
postpartum
day
ppd
see
fig
pid
pcd
protect
diseas
upon
challeng
homolog
viru
yuan
et
al
relationship
also
demonstr
human
pediatr
patient
circul
rotavirusspecif
iga
asc
correl
rotavirusspecif
iga
asc
small
intestin
lamina
propria
brown
et
al
specif
time
frame
cellular
traffick
gut
mucos
tissu
highlight
assess
lymphoprolif
respons
intestin
mesenter
lymph
node
ileal
lamina
propria
circul
blood
system
spleen
mononuclear
cell
rotaviru
challeng
gnotobiot
pig
rotavirusspecif
lymphoprolif
respons
blood
correl
rotavirusspecif
lymphoprolif
respons
intestin
earli
rotaviru
inocul
challeng
furthermor
magnitud
lymphoprolif
respons
posit
correl
number
rotavirusspecif
asc
support
hypothesi
lymphoprolifer
quantifi
function
traffick
thelpercel
subsequ
help
stimul
antibodi
product
b
cell
ward
et
al
yuan
et
al
studi
highlight
import
identifi
window
time
immunocyt
asc
traffic
blood
gut
mammari
gland
postpedv
challeng
gilt
sow
previou
work
demonstr
immun
factor
associ
intestin
mucos
immun
like
siga
import
correl
immun
regard
pedv
recent
report
research
determin
follow
inocul
pedv
viru
shed
significantli
reduc
nurs
piglet
receiv
passiv
lactogen
immun
linear
relationship
detect
fecal
viral
rna
shed
piglet
iga
antibodi
level
milk
piglet
receiv
milk
higher
iga
antibodi
titer
significantli
lower
pedv
rna
shed
fece
ad
evid
iga
antibodi
play
role
lactogen
immun
pedv
passiv
protect
neonat
piglet
recent
work
suggest
system
antibodi
also
contribut
protect
pedv
poonsuk
et
al
b
studi
neonat
piglet
intraperiton
administ
vari
concentr
antipedv
serum
antibodi
day
age
follow
pedv
inocul
h
later
piglet
posit
circul
antipedv
antibodi
return
normal
bodi
temperatur
faster
experienc
less
mortal
postpedv
inocul
compar
piglet
neg
pedv
antibodi
howev
piglet
growth
rate
pedv
fecal
shed
humor
immun
respons
improv
intraperiton
administr
antipedv
serum
antibodi
system
antibodi
may
play
role
pedv
clearanc
like
protect
neonat
piglet
mostli
attribut
matern
secretori
iga
milk
recent
case
studi
evalu
respons
oral
immun
sow
product
unit
feed
back
intestin
euthan
moribund
neonat
parenter
immun
commerci
pedv
vaccin
support
hypothesi
first
product
unit
unit
nonpedv
infect
gilt
sow
receiv
harrisvaccin
inc
first
gener
pedv
vaccin
ipe
intramuscularli
week
prefarrow
ipe
vaccin
formul
alphavirusbas
express
vector
technolog
use
recombin
venezuelan
equin
enceph
viru
vee
strain
replicon
express
pedv
spike
glycoprotein
recombin
vee
viru
particl
encapsul
pedv
rna
harvest
infect
vero
cell
vee
replicon
rna
express
gene
recov
use
ipe
vaccin
kim
et
al
vaccin
gilt
sow
product
unit
gener
low
neglig
serum
pedv
igg
milk
pedv
neutral
antibodi
titer
second
product
unit
unit
b
gilt
sow
given
oral
immun
feedback
month
prefarrow
time
initi
pedv
outbreak
anim
high
pedv
neutral
antibodi
titer
milk
pedv
igg
antibodi
detect
serum
third
product
unit
unit
c
sow
given
oral
immun
feedback
success
day
initi
pedv
outbreak
farm
pedv
neutral
igg
antibodi
detect
milk
serum
respect
suggest
success
gener
milk
pedv
neutral
antibodi
titer
depend
oral
exposur
oral
immun
sow
seen
tgev
addit
describ
tgev
serum
igg
antibodi
titer
may
correl
immun
pedv
saif
bohl
saif
et
al
scherba
colleagu
also
vaccin
gilt
sow
fourth
product
unit
unit
parenter
ipe
vaccin
week
prefarrow
addit
oral
immun
feedback
week
prefarrow
two
pedv
outbreak
product
unit
also
experienc
third
pedv
outbreak
shortli
farrow
serum
pedv
igg
antibodi
level
wane
week
prefarrow
gilt
sow
unit
level
coincid
pedv
neutral
antibodi
titer
milk
support
lack
relationship
serum
igg
antibodi
milk
viru
neutral
antibodi
titer
pedv
scherba
et
al
author
includ
control
group
three
gilt
hous
isol
research
facil
neither
infect
vaccin
sampl
time
point
product
unit
omiss
studi
lack
analysi
level
pedv
iga
antibodi
serum
milk
lack
report
piglet
mortal
protect
rate
subsequ
outbreak
studi
conduct
product
swine
facil
pedv
piglet
challeng
studi
possibl
import
note
product
unit
bd
experienc
pedv
outbreak
addit
oral
immun
feedback
anim
product
unit
would
receiv
vari
dose
pedv
depend
product
unit
manag
practic
environment
pedv
load
lastli
author
state
product
unit
pedv
serolog
data
present
confirm
serum
free
pedv
antibodi
viral
infect
subset
antibodi
gener
abil
neutral
viral
pathogen
antigen
bind
site
paratop
variabl
domain
antibodi
must
bind
epitop
antigen
associ
viru
neutral
mechan
antibodi
neutral
includ
inhibit
mani
part
viru
infect
cycl
includ
cellular
surfac
bind
fusion
entri
endocytosi
andor
viral
replic
within
cell
klass
sattentau
mani
licens
vaccin
neutral
antibodi
provid
qualiti
correl
vaccin
efficaci
zinkernagel
pedv
alphacoronaviru
least
seven
open
read
frame
orf
encod
four
major
structur
protein
spike
envelop
e
membran
nucleocapsid
n
accessori
proteinencod
gene
huang
et
al
protein
form
characterist
protrud
spike
situat
outsid
nucleocapsid
consist
two
domain
domain
associ
bind
host
cellular
receptor
mediat
viral
fusion
entri
cell
bosch
et
al
sturman
et
al
wicht
et
al
tgev
domain
potent
induc
viru
neutral
antibodi
import
piglet
protect
previou
work
pedv
protein
demonstr
region
design
aa
react
pedv
antiserum
elicit
pedv
neutral
antibodi
titer
mice
sun
et
al
addit
passiv
immun
neonat
piglet
oral
administr
egg
yolk
antibodi
igi
specif
domain
provid
protect
postpedv
challeng
kweon
et
al
howev
due
lack
neg
control
pedvchalleng
nonspecif
igi
treatment
piglet
unknown
non
immun
igi
could
also
mediat
passiv
protect
abil
induc
neutral
antibodi
conserv
across
mani
coronavirus
includ
sever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
member
betacoronaviru
genera
sui
et
al
yu
et
al
abil
stimul
neutral
antibodi
may
make
attract
booster
vaccin
initi
pedv
prime
gut
park
et
al
interfer
siga
bind
spike
ectodomain
receptorbind
subunit
membran
fusion
subunit
pedv
would
inhibit
cell
entri
subsequ
viral
infect
therefor
suffici
amount
siga
lumen
neonat
piglet
import
prevent
infect
pedvrel
death
sow
given
south
korean
vaccin
strain
attenu
strain
oral
provid
greater
passiv
protect
piglet
mortal
compar
mother
given
vaccin
intramuscularli
mortal
song
et
al
result
studi
agreement
previou
literatur
oral
vs
intramuscular
rout
induct
gutmammarysiga
axi
coincid
increas
serum
iga
pedv
antibodi
farrow
pregnant
sow
infect
via
oral
rout
compar
inocul
intramuscularli
howev
neutral
antibodi
titer
differ
serum
sow
given
oral
intramuscular
vaccin
howev
oral
inocul
sow
increas
colostrum
pedv
neutral
antibodi
titer
compar
intramuscularli
inocul
sow
increas
colostrum
pedv
neutral
antibodi
titer
oral
sow
associ
increas
serum
iga
pedv
antibodi
also
neutral
antibodi
titer
increas
piglet
sera
day
age
prechalleng
born
sow
infect
via
oral
compar
intramuscular
rout
result
suggest
colostrummilk
neutral
antibodi
titer
induc
oral
inocul
sow
better
reflect
piglet
protect
attenu
pedv
vaccin
colostrummilk
antibodi
correl
protect
immun
may
consist
diagnost
tool
determin
vaccin
efficaci
system
antibodi
respons
describ
earlier
gut
deriv
iga
asc
traffick
transient
serum
correl
immun
enter
infect
convent
piglet
given
either
virul
attenu
pedv
strain
piglet
given
virul
strain
induc
specif
asc
blood
intestin
spleen
postinocul
pedvchalleng
piglet
previous
inocul
virul
strain
increas
iga
igg
asc
intestin
compar
piglet
given
attenu
strain
strong
posit
correl
protect
asc
respons
detect
gut
lymphoid
tissu
blood
de
arriba
et
al
gestat
sow
expos
pedv
field
iga
igg
pedvspecif
asc
detect
intestin
sow
month
postpedv
exposur
number
asc
wane
still
detect
sow
intestin
month
postpedv
exposur
ouyang
et
al
howev
latter
studi
investig
pedvspecif
asc
traffick
blood
addit
anim
pedvinfect
field
maintain
respect
farm
may
reexpos
vari
dose
pedv
time
initi
infect
slaughter
would
confound
conclus
relat
durat
immun
assum
singl
time
point
exposur
sow
research
need
control
environ
anim
experiment
infect
piglet
pedv
challeng
lactogen
protect
neonat
mortal
measur
addit
blood
analysi
pedvspecif
asc
need
determin
blood
asc
correl
lactogen
protect
observ
rotaviru
tgev
matern
vaccin
strategi
induc
lactogen
immun
tgev
review
saif
saif
et
al
also
applic
emerg
enter
infect
pedv
summar
prior
research
attenu
oral
tgev
vaccin
administ
multipl
dose
pregnant
sow
usual
dose
week
prepartum
induc
siga
antibodi
milk
variabl
rate
passiv
protect
howev
milk
siga
antibodi
level
piglet
protect
rate
consist
lower
sow
given
attenu
oral
tgev
sow
inocul
virul
tgev
strain
reason
discrep
may
includ
lower
viral
dose
vaccin
loss
gastrointestin
stabil
subsequ
viral
replic
gut
sow
viru
attenu
latter
import
sometim
overlook
variabl
tgev
challeng
studi
vaccin
sow
litter
vaccin
fail
induc
activ
immun
gut
sow
becam
ill
develop
diarrhea
anorexia
ceas
milk
product
invari
mortal
rate
among
nurs
piglet
high
saif
et
al
thu
activ
mucos
immun
protect
gut
sow
critic
success
tgev
pedv
matern
vaccin
mention
previous
parenter
immun
seroneg
sow
inactiv
subunit
tgev
vaccin
induc
mucos
immun
elicit
mainli
system
igg
antibodi
domin
serum
colostrum
declin
rapidli
milk
provid
littl
lactogen
immun
piglet
except
extrem
high
level
igg
antibodi
induc
serum
transud
colostrum
remain
elev
milk
protect
neonat
transient
first
week
life
regard
whether
kill
live
inject
intramuscular
pedv
vaccin
gener
suffici
immun
pedv
sow
paudel
et
al
analyz
sow
given
one
four
vaccin
treatment
unvaccin
neg
control
group
kill
viru
vaccin
group
kill
viru
booster
kk
live
viru
vaccin
group
live
viru
booster
combin
group
given
live
viru
kill
viru
booster
lk
vaccin
includ
use
live
viru
given
intramuscularli
twice
four
two
week
prior
farrow
sow
confirm
pedv
neg
antibodi
elisa
serum
rtpcr
use
fecal
sampl
pedvneg
sow
use
investig
demonstr
sow
given
kk
treatment
higher
igg
iga
antibodi
titer
neutral
activ
serum
colostrum
piglet
serum
lowest
level
group
due
intramuscular
inject
rout
live
viru
vaccin
viru
unlik
reach
gut
replic
intestin
enterocyt
sow
therefor
studi
may
provid
inform
regard
vaccin
immunogen
reflect
immun
respons
live
oral
pedv
exposur
addit
pedv
challeng
piglet
necessari
determin
kk
vaccin
treatment
also
provid
suffici
lactogen
immun
piglet
protect
diseas
paudel
et
al
mani
unansw
question
relat
time
mechan
iga
immunocyt
home
intestin
mammari
gland
relat
vaccin
approach
herd
immun
statu
studi
investig
optim
gestat
matern
vaccin
time
interv
gener
suffici
lactogen
immun
similarli
detail
studi
done
compar
vaccin
respons
gilt
vs
sow
gilt
sow
import
question
gutmammarysiga
axi
initi
gestat
evok
prepubesc
gilt
expos
viru
first
report
experiment
sow
studi
us
pedv
isol
sow
averag
pariti
herd
natur
infect
mild
sindel
strain
pedv
use
farm
sow
also
receiv
live
viru
exposur
origin
field
isol
month
later
move
isol
facil
experiment
reexpos
virul
pedv
isol
day
gestat
daysofag
piglet
also
receiv
oral
challeng
virul
viru
surviv
challeng
one
week
age
monitor
pedv
posit
sow
group
piglet
surviv
challeng
compar
sow
group
experienc
mortal
rate
goed
et
al
studi
demonstr
sow
field
could
produc
lactogen
immun
howev
piglet
protect
infect
complet
variabl
among
litter
indic
could
number
factor
influenc
outcom
recent
report
research
detect
pedv
serum
antibodi
titer
least
five
month
field
exposur
sow
howev
pedv
challeng
studi
suckl
piglet
gilt
previous
expos
pedv
sexual
matur
prior
concept
necessari
determin
induct
lactogen
immun
gilt
sow
associ
piglet
passiv
protect
schelkopf
et
al
anoth
import
question
dose
extent
viru
replic
giltsow
intestin
impact
induct
iga
antibodi
milk
whether
suffici
piglet
protect
pedv
describ
previous
tgev
vaccin
research
replic
pedv
sow
gut
case
attenu
vaccin
stabil
immunogen
pedv
vaccin
antigen
need
induc
pedv
neutral
antibodi
titer
consid
design
matern
vaccin
feedback
approach
herd
categor
three
gener
status
base
presenc
pedv
antibodi
clinic
sign
pedvneg
herd
herd
never
infect
pedvact
herd
ongo
clinic
diseas
viru
detect
rtqpcr
pedvstabl
herd
previous
experienc
epidem
subsequ
clinic
diseas
recogn
herd
neg
pedv
fecal
shed
base
rtqpcr
test
sow
pedvantibodi
posit
begin
fourth
year
pedv
us
pedvact
herd
one
like
previous
infect
earlier
epidem
case
clinic
diseas
usual
extens
pedv
first
enter
herd
suggest
albeit
insuffici
matern
immun
sow
goed
morrison
although
incid
new
pedv
case
us
declin
dramat
sinc
winter
still
occasion
case
pedvneg
herd
becom
infect
first
time
experienc
dramat
loss
first
report
http
wwwaphisusdagovaphisourfocusanimalhealth
animaldiseaseinformationswinediseaseinformationct
ped
info
differ
pedv
status
describ
earlier
may
provid
insight
possibl
pedv
control
strategi
howev
difficult
gener
us
pig
rais
use
multisit
product
deriv
sow
farm
contain
cohous
sow
addit
site
may
complex
larg
sow
barn
locat
close
togeth
contrast
tradit
farrowtofinish
farm
locat
one
site
contain
rel
small
number
sow
divers
swine
husbandri
contribut
complex
epidemiolog
swine
diseas
may
especi
true
pedv
initi
attempt
control
ped
involv
feedback
control
whole
herd
exposur
involv
expos
entir
sow
herd
infecti
materi
ie
fece
gut
tissu
collect
infect
piglet
attempt
stimul
activ
pedv
immun
http
wwwaasvorg
goal
develop
pedv
immun
sow
would
transfer
piglet
colostrummilk
would
protect
young
piglet
vulner
gener
strategi
seem
work
well
sinc
incid
clinic
diseas
declin
dramat
feedback
effect
goed
morrison
appar
failur
feedback
practic
consist
reduc
elimin
clinic
diseas
rais
question
durat
qualiti
sow
immun
follow
control
infect
addit
question
difficulti
tri
expos
larg
group
sow
viru
qualiti
biolog
materi
use
feedback
well
worker
actual
perform
task
modif
feedback
strategi
involv
multipl
feedback
attempt
expos
sow
time
two
week
period
goal
make
sure
sow
least
one
exposur
infecti
viru
http
www
practic
improv
condit
farm
still
field
report
farm
would
chronic
low
level
clinic
diseas
suggest
breed
herd
immun
feedback
program
sow
actual
immun
infect
wildtyp
viru
piglet
still
clinic
affect
durat
magnitud
sow
immun
consid
inadequ
live
viru
feedback
program
may
aggress
sow
near
time
farrow
may
lead
sow
shed
overwhelm
dose
challeng
viru
farrow
room
field
observ
highlight
gap
knowledg
influenc
lactogen
immun
femal
passiv
protect
pedv
suckl
piglet
feedback
may
fail
similar
reason
attenu
vaccin
fail
viru
dose
low
viru
noninfecti
due
inadequ
samplingstorag
condit
swine
alreadi
preexist
immun
block
viral
replic
gut
gestat
stage
time
feedback
influenc
lactogen
immun
describ
earlier
ackerman
us
epidem
enter
fourth
year
field
case
report
publish
goed
morrison
hough
thoma
lesson
grow
bodi
work
feedback
strategi
help
mani
farm
reduc
loss
acut
phase
outbreak
seem
prevent
futur
diseas
ie
pedvstabl
herd
howev
farm
use
feedback
practic
difficult
time
control
diseas
pedvact
herd
neg
statu
smaller
herd
may
reflect
less
movement
incom
pig
potenti
fewer
contamin
vehicl
cloth
worker
also
smaller
farm
complianc
worker
easier
monitor
larger
farm
smaller
farm
also
geograph
separ
larger
system
locat
close
togeth
current
us
swine
herd
never
infect
pedv
may
reflect
high
level
adher
strict
biosecur
practic
herd
pedvstabl
herd
demonstr
herd
infect
elimin
pedv
site
maintain
viru
free
pedvact
herd
gener
larg
herd
singl
site
difficult
elimin
viru
farm
endem
pedv
infect
probabl
reflect
lack
immun
sow
herd
presenc
uniqu
environment
stabl
viru
reinfect
sow
presum
pedv
isol
physic
similar
sensit
disinfect
desicc
etc
thu
differ
farm
relat
farmspecif
activ
feedback
approach
novel
viru
strain
may
pedvstabl
herd
typic
smaller
thu
like
thoroughli
disinfect
larger
site
addit
experiment
evid
infecti
pedv
detect
fecal
slurri
http
manur
storag
lagoon
tun
et
al
extend
period
time
could
serv
potenti
reservoir
infecti
viru
reinfect
farm
differ
manur
handl
small
larg
farm
might
explain
differ
pedvstabl
activ
site
allinallout
manag
practic
versu
continu
farrow
oper
continu
sourc
newborn
piglet
may
also
influenc
pedv
transmiss
persist
within
herd
despit
effort
control
intra
interfarm
pedv
transmiss
swine
herd
still
vulner
infect
movement
contamin
feed
recent
field
report
experi
support
movement
contamin
feed
like
sourc
infect
number
farm
bowman
et
al
dee
et
al
dee
et
al
kochhar
support
work
hypothesi
chines
origin
pedv
epidem
huang
et
al
studi
enter
viru
vaccin
tgev
rotaviru
swine
polioviru
children
jafari
et
al
john
et
al
suggest
effect
prime
gut
natur
infect
oral
attenu
vaccin
parenter
subunit
inactiv
booster
vaccin
could
enhanc
maintain
mucos
lactogen
immun
oral
primeparenter
booster
approach
may
explain
parenter
vaccin
effect
certain
scenario
sow
recov
tgev
rotaviru
infect
use
oral
attenu
vaccin
saif
saif
et
al
exampl
parenter
tgev
spike
subunit
vaccin
contain
viru
neutral
epitop
alon
effect
induc
milk
siga
antibodi
passiv
protect
tge
seroneg
pregnant
sow
shoup
et
al
howev
use
booster
vaccin
oral
prime
sow
spike
subunit
inactiv
tgev
vaccin
enhanc
milk
siga
antibodi
titer
passiv
protect
park
et
al
likewis
nonrepl
rotaviruslikeparticl
vaccin
fail
induc
siga
intestin
antibodi
activ
protect
piglet
effect
oral
attenu
rotaviru
booster
vaccin
piglet
prime
oral
rotaviru
vaccin
azevedo
et
al
enhanc
lactogen
immun
subsequ
immun
protect
piglet
may
also
accomplish
boost
oral
prime
anim
parenter
vaccin
describ
earlier
demonstr
viral
infect
stimul
intestin
mucosa
influenc
lactogen
immun
via
gutmammarysiga
axi
model
system
also
applic
pedv
similar
matern
vaccin
strategi
may
need
gutmammarysiga
axi
initi
piglet
protect
recent
report
investig
compar
effect
intramuscular
inject
inactiv
kill
pedv
vaccin
zoeti
inc
given
pregnant
sow
five
two
week
prefarrow
either
previous
expos
field
pedv
pedv
although
neg
control
sow
categor
pedv
uninfect
rtpcr
serolog
data
present
confirm
sow
statu
piglet
oral
challeng
day
age
fece
piglet
inocul
pedv
birth
dilut
pcr
cyclethreshold
ct
report
show
pedv
previous
expos
sow
significantli
increas
pedv
iga
antibodi
level
serum
milk
compar
sow
vaccin
inactiv
kill
vaccin
provid
booster
effect
either
group
piglet
mortal
invers
relat
iga
pedv
antibodi
titer
colostrum
milk
mortal
occur
litter
previous
expos
sow
detect
iga
antibodi
colostrum
milk
contrast
piglet
sow
higher
mortal
rate
compar
previous
expos
group
regardless
vaccin
statu
inactiv
kill
vaccin
stimul
statist
signific
increas
serum
pedv
igg
antibodi
titer
significantli
increas
serum
milk
pedv
iga
antibodi
titer
previous
expos
sow
report
suggest
inactiv
kill
vaccin
condit
time
administr
test
effect
primari
booster
vaccin
previous
pedvexpos
sow
respect
induc
lactogen
immun
schwartz
et
al
due
mark
decreas
pedv
outbreak
europ
pedv
vaccin
develop
target
asian
countri
experienc
increas
outbreak
virul
pedv
strain
econom
impact
pedv
greatest
sinc
inactiv
bival
tgev
pedv
vaccin
use
china
et
al
addit
attenu
pedv
vaccin
develop
attenu
pedv
strain
use
chines
pig
popul
vaccin
particularli
inactiv
bival
tgevpedv
vaccin
use
extens
tri
control
pedv
howev
reemerg
highli
virul
pedv
china
demand
efficaci
vaccin
control
current
outbreak
lack
vaccineinduc
piglet
protect
seen
chines
outbreak
may
due
differ
highli
virul
reemerg
strain
classic
pedv
vaccin
strain
base
genet
analysi
gene
remain
unproven
classic
virul
emerg
strain
induc
crossneutr
antibodi
lin
et
al
song
et
al
provid
efficaci
vaccin
trival
vaccin
consist
tgev
pedv
rotaviru
licens
chines
ministri
agricultur
decemb
song
et
al
reportedli
demonstr
increas
protect
rate
swine
experiment
farm
detail
studi
propos
efficaci
mechan
immun
publish
south
korea
use
oral
vaccin
attenu
pedv
vaccin
sinc
south
korean
strain
serial
passag
vero
cell
cultur
passag
nine
nucleotid
chang
cours
attenu
sequenc
variat
orf
gene
determin
restrict
fragment
length
polymorph
analysi
song
park
japan
commerci
attenu
viru
vaccin
cell
cultur
adapt
pedv
administ
sow
sinc
vaccin
consid
efficaci
report
sow
given
vaccin
develop
solid
lactogen
immun
song
et
al
sever
issu
address
lactogen
immun
low
includ
domin
immunogen
vaccin
stabil
dose
rout
administr
well
paramet
discuss
earlier
sinc
outbreak
us
condit
licens
two
pedv
vaccin
first
vaccin
develop
harrisvaccin
tm
base
alphavirusbas
express
vector
technolog
describ
earlier
vander
veen
et
al
first
gener
vaccin
ipe
releas
limit
use
basi
second
gener
ipe
vaccin
releas
januari
ipe
vaccin
incorpor
longer
segment
spike
gene
ipe
vaccin
harrisvaccin
inc
pedv
vaccin
label
dose
intramuscularli
sow
gilt
prefarrow
secondli
inactiv
kill
vaccin
pedv
develop
zoeti
inc
florham
park
new
jersey
zoeti
inc
vaccin
label
dose
given
intramuscularli
sow
gilt
prefarrow
two
vaccin
use
us
lack
publish
data
field
efficaci
correl
immun
research
need
determin
efficaci
vaccin
experiment
trial
field
identifi
immun
correl
piglet
protect
suckl
neonat
gener
suffici
lactogen
immun
integr
passiv
lactogen
protect
pedv
suckl
neonat
much
learn
matern
vaccin
effort
tgev
emerg
prcv
induc
crossprotect
tgev
allow
delin
detail
variabl
relat
mechan
gutmammarysiga
axi
lactogen
immun
current
research
suggest
colostrum
milk
iga
pedv
neutral
antibodi
titer
may
correl
protect
immun
pedv
addit
research
lab
suggest
suffici
level
iga
pedv
neutral
antibodi
titer
lactogen
secret
may
depend
viral
dose
extent
replic
gut
gilt
howev
much
still
unknown
mechan
induc
maintain
gutmammarysiga
axi
numer
factor
may
contribut
wane
immun
seen
field
particularli
even
aggress
feedback
procedur
field
observ
lack
lactogen
immun
seen
vaccin
trial
asia
highlight
gap
knowledg
influenc
induct
lactogen
immun
factor
includ
dose
inocul
immunogen
viral
strain
andor
vaccin
viral
antigen
use
age
giltsow
sexual
matur
anim
gestat
stage
vaccin
imper
develop
vaccin
strategi
target
pregnant
lactat
swine
respons
identifi
factor
influenc
lactogen
immun
may
lead
improv
pedv
enter
pathogen
vaccin
regimen
gestat
swine
improv
overal
herd
immun
industri
product
none
author
paper
financi
person
relationship
peopl
organ
could
inappropri
influenc
bia
content
paper
